Melo presents at NR-SIG-WFNR and INS 2026 with the Royal Hospital for Neuro-disability

Dr Natali Farran, Clinical Psychologist at the Royal Hospital for Neuro-disability, with Melo co-founder James Burch at INS 2026 in Dublin.

Our co-founders, James Burch and James Chapman, and Dr Natali Farran of the Royal Hospital for Neuro-disability took a one-year service evaluation of Melo to NR-SIG-WFNR in Belfast and INS 2026 in Dublin.



What we presented at NR-SIG-WFNR in Belfast

The 23rd conference of the Neuropsychological Rehabilitation Special Interest Group of the World Federation for NeuroRehabilitation (NR-SIG-WFNR) ran on 19 and 20 July at the Hilton Belfast. Two datablitz sessions came out of our work with the Royal Hospital for Neuro-disability (RHN): 

  • From Data Burden to Clinical Insight: A One-Year Service Evaluation of Melo in Specialist Neurorehabilitation, presented by our co-founder James Chapman 

  • Service Development in Practice: Successfully Implementing Melo in a Specialist Neuro-behavioural Inpatient Service, presented by Dr Natali Farran, Clinical Psychologist at RHN 


RHN’s neuro-behavioural team (Goodman House) has been using Melo since early 2025 and has now completed more than 5,000 assessments digitally. In their feedback, 78% reported entries were much faster with Melo, 78% said it produced better quality data, and 89% found it easier to use than existing systems.

 

See what a year of behavioural data looks like on your own ward. 

Melo records observations and standardised assessments in one place.

 

James Chapman presenting the RHN service evaluation at NR-SIG-WFNR in Belfast, July 2026.

What we showed at INS 2026 in Dublin

The International Neuropsychological Society brought its 2026 Mid-Year Meeting to Trinity Business School in Dublin, from 22 to 24 July. Co-founder James Burch and Dr Farran presented both pieces of work as posters on the Friday afternoon.

 

Working with the Royal Hospital for Neuro-disability

Both posters carry RHN’s name alongside ours. Dr Farran and her colleagues implemented Melo on Wellesley Ward, RHN’s specialist neuro-behavioural inpatient service, and then evaluated it over a year.

On that ward, clinicians regularly have to evidence the need for 1:1 support to the Integrated Care Board, and those decisions determine whether funding continues. Ward managers used Melo’s behavioural charts to support one of those cases for the first time this year. 

 
Melo is such an important, useful and exciting development in the world of managing behaviour that challenges. Melo is a straightforward and clear app to track behaviour that challenges after brain injury. This will help us improve the data collection and how we utilise the data on our wards.
— Dr Alex Rose, Consultant Clinical Psychologist and Neurobehavioural Programme Lead, RHN
 
Research poster titled "From Data Burden to Clinical Insight", co-branded by Melo and the Royal Hospital for Neuro-disability.

Poster: From Data Burden to Clinical Insight, a one-year service evaluation of Melo in specialist neurorehabilitation.

Missed us in Belfast or Dublin?

Here's the short version. Melo puts behavioural observations and assessments like the OAS-MNR and SASBA in one place, so the whole ward sees patterns early. 

 

See what that looks like on your own ward.

Start with the assessments your team already runs, the OAS-MNR and SASBA included.

Next
Next

Melo Awarded Funding Through STFC's NHS Fit for the Future Missions R&D Accelerator in Partnership with NHS University Hospitals of Liverpool Group